STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 102 filers reported holding STOKE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,639,500 | +45.8% | 394,312 | +102.8% | 0.00% | 0.0% |
| Q3 2022 | $2,496,250 | -2.8% | 194,412 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $2,568,183 | -16.2% | 194,412 | +33.5% | 0.00% | 0.0% |
| Q1 2022 | $3,064,880 | +166.5% | 145,600 | +222.1% | 0.00% | – |
| Q3 2021 | $1,150,000 | +114.2% | 45,200 | +80.8% | 0.00% | – |
| Q3 2019 | $537,000 | -26.3% | 25,000 | 0.0% | 0.00% | – |
| Q2 2019 | $729,000 | – | 25,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 296,822 | $9,991,000 | 2.07% |
| RTW INVESTMENTS, LP | 3,644,248 | $122,665,000 | 1.85% |
| Cormorant Asset Management, LP | 1,278,276 | $43,027,000 | 1.46% |
| Redmile Group, LLC | 2,458,558 | $82,755,000 | 1.22% |
| SPHERA FUNDS MANAGEMENT LTD. | 233,135 | $7,847,000 | 0.53% |
| Birchview Capital, LP | 15,000 | $505,000 | 0.30% |
| Perceptive Advisors | 1,343,956 | $45,238,000 | 0.29% |
| GILDER GAGNON HOWE & CO LLC | 1,245,956 | $41,939,000 | 0.21% |
| Artal Group S.A. | 250,000 | $8,415,000 | 0.17% |
| Casdin Capital, LLC | 120,000 | $4,039,000 | 0.10% |